Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$518.81 - $607.81 $535,930 - $627,867
-1,033 Reduced 28.78%
2,556 $1.49 Million
Q1 2024

Apr 24, 2024

BUY
$473.42 - $539.26 $544,906 - $620,688
1,151 Added 47.21%
3,589 $1.93 Million
Q4 2023

Jan 25, 2024

BUY
$437.42 - $470.64 $34,993 - $37,651
80 Added 3.39%
2,438 $1.13 Million
Q3 2023

Oct 25, 2023

BUY
$402.4 - $446.42 $260,352 - $288,833
647 Added 37.81%
2,358 $1.03 Million
Q1 2023

Apr 26, 2023

SELL
$335.35 - $386.06 $215,294 - $247,850
-642 Reduced 27.28%
1,711 $609,000
Q4 2022

Jan 31, 2023

SELL
$346.68 - $397.58 $15,253 - $17,493
-44 Reduced 1.84%
2,353 $882,000
Q3 2022

Oct 18, 2022

BUY
$321.25 - $373.84 $770,036 - $896,094
2,397 New
2,397 $815,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Wespac Advisors, LLC Portfolio

Follow Wespac Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors, LLC with notifications on news.